In a world where medical advancements have conquered countless diseases, a silent yet deadly threat looms large—drug-resistant fungal infections are claiming millions of lives each year, often with little public attention. These infections strike hardest at the most vulnerable, such as cancer
In a groundbreaking moment for the biotechnology sector, San Diego-based startup Iambic has captured the spotlight by raising an impressive $100 million in Series B financing to propel clinical trials of its AI-discovered cancer drugs, marking a significant milestone for the company. This
In a monumental step forward for medical science, the announcement of the world’s first clinical trial for a lung cancer prevention vaccine, known as LungVax, marks a turning point in the battle against one of the deadliest diseases globally, with the trial slated to commence in 2026. Developed
Glioblastoma, recognized as the most aggressive and common form of brain cancer, especially in its IDH wild-type variant, remains a daunting challenge with survival rates often limited to about a year despite intensive treatments like surgery, radiotherapy, and chemotherapy. A groundbreaking study
In a groundbreaking stride for neuroscience, the Allen Institute for Brain Science has unveiled the Brain Knowledge Platform (BKP), a pioneering digital database that promises to redefine how the global scientific community approaches brain research. Loaded with data from over 34 million brain
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the healthcare industry. Ivan has dedicated much of his career to advancing research and development, particularly in the intersection of technology and organ
